Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Astrana Health, Inc. (NASDAQ: ASTH)
ASTH Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
35.90%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
-39.70%
ASTH Stock Analysis
ASTH
PE Ratio:
59.2
ASTH
PEG Ratio:
1.1
ASTH
Forward EPS Growth (12 month):
54.30%
ASTH
PS Ratio:
0.5
ASTH
PSG Ratio:
0.1
ASTH
Forward Revenue Growth (12 month):
9.70%
ASTH Articles
No data was found